AGONISTISCHE CD40-ANTIKÖRPER
European patent · EP3684813 · In force
Register entry
- Publication number
- EP3684813
- Application number
- EP18778857
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Sep 19, 2018
- Published
- Jul 29, 2020
- Granted
- Oct 8, 2025
- Protection ends at the latest
- Sep 18, 2038
- Next annual fee due
- Sep 30, 2027
- IPC classes
- A61K 39/395 (2006.01)
- Priority
- EP 17191974 19.09.2017
- PCT application
- PCT/EP2018/075388 19.09.2018
- PCT publication
- WO2019/057792 28.03.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.09.2026 → 30.09.2027
Published in Swissreg on 01.10.2026
- Aug 19, 2026
Change
Published in Swissreg on 19.08.2026
- Dec 30, 2025
Agent entered
- Representative
- BOVARD AG, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 30.12.2025
- Oct 8, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 08.10.2025
Parties
Inventor
FISCHER, Stephan
82362 Weilheim, DE
BECKMANN, Karsten
85591 Vaterstetten, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.